References
- Krejs G J. Gastrointestinal endocrine tumors. Am J Med 1987; 82 Suppl 5B: 1–3
- Zollinger R M, Ellison E H. Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955; 142: 709
- Rambaud J C, Modigliani R, Emonts P, Matuchansky C, Vidon N, de Recherce M, et al. Fluid secretion in the duodenum and intestinal handling of water and electrolytes in Zollinger-Ellison syndrome. Dig Dis 1978; 23: 1089
- Guillausseau P J, Guillausseau C, Villet R, Kaloustian E, Valleur P, Hautefeuille P, Lubetzki J. Les Glucagonomes. Aspects cliniques, biologiques, anatomopathologiques et therapeutiques. Gastroenterol Clin Biol 1982; 6: 1029
- Santangelo W C, Unger R H, Orci L, Dueno M I, Popma J J, Krejs G J. Somatostatin analog-induced remission of necrolytic migratory erythema without changes in plasma glucagon concentration. Pancreas 1986; 1: 464–9
- Verner J V, Morrison A B. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958; 25: 374
- Bloom S R, Polak J M, Pearse A GE. Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet 1973; ii: 4
- Krejs G J, Fordtran J S, Bloom S R, Fahrenkrug J, Schaffalitzky de Muckadell O B, Fischer J E, et al. Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology 1980; 78: 722–7
- Kane M G, O'Dorisio T M, Krejs G J. Intravenous VIP infusion causes secretory diarrhea in man. N Engl J Med 1983; 309: 1482–5
- Krejs G J. VIPoma syndrome. Am J Med 1987; 82 Suppl 5B: 37–48
- Krejs G J, Orci L, Conlon J M, Ravazzola M, Davis G R, Raskin P, et al. Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med 1979; 301: 285–92
- Marcial M A, Pinkus G S, Skarin A, Hinrichs H R, Warhol M J. Ampullary somatostatinoma: Psammomatous variant of gastrointestinal carcinoid tumor—an immunohistochemical and ultra-structural study. Report of a case and review of the literature. Am J Clin Pathol 1983; 80: 755
- Weekly clinicopathological conference. N Engl J Med 1989; 320: 996–1004, Case 15–1989
- Krejs G J. Non-insulin-secreting tumors of the gastroenteropancreatic system. Williams Textbook of Endocrinology, 8th ed., D W Foster, J D Wilson. W. B. Saunders, Philadelphia, London, Toronto 1992; 1567–76
- Rivier J, Spiess J, Thorner M, Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982; 300: 276–8
- Lipp R W, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs G J. Radiolabeled octreotide for the demonstation of somatostatin receptors in malignant lymphoma and lymphadenopathy. J Nucl Med 1995; 36: 13–8
- Rösch T, Lightdale C J, Botet J F, Boyce G A, Sivak M V, Yasuda K. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992; 326: 1721–6
- Arnold R, Neuhaus C, Benning R, Schwerk W B, Trautmann M E, Joseph K, Bruns C. Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metatstatic endocrine gastroenteropancreatic tumors. World J Surg 1993; 17: 511–9
- Janson E T, öberg K. Long-term management of the carcinoid syndrome. Acta Oncologica 1993; 32: 225–9
- Nold R, Frank M, Kajdan U, Trost U, Klose K J, Arnold R. Kombinierte Behandlung metastasierter endokriner Tumoren des Gastrointestinaltrakts mit Octreotid und Interferon-Alpha. Z Gastroenterol 1994; 32: 193–7